SMMT Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 122649 min ago

@ $4.41

Wydano: 14 vas. 2024 @ 22:08

Zwrot: 8.39%

Poprzedni sygnał: vas. 14 - 21:15

Poprzedni sygnał: Sprzedaż

Zwrot: -0.23 %

Live Chart Being Loaded With Signals

Commentary (9 geg. 2024 @ 23:00):

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America...

Stats
Dzisiejszy wolumen	2.08M
Średni wolumen	2.28M
Kapitalizacja rynkowa	3.36B
EPS	$0 ( 2024-05-01 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	12.58
ATR14	$0.0110 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Ronaghi Mostafa	Buy	25 315	Stock Option (right to buy)
2024-04-11	Ronaghi Mostafa	Buy	200 000	Stock Option (right to buy)
2024-04-11	Ronaghi Mostafa	Buy	0
2024-04-02	Soni Manmeet Singh	Buy	1 100 000	Stock Option (right to buy)
2024-04-02	Anand Bhaskar	Buy	600 000	Stock Option (right to buy)

INSIDER POWER
99.42
Last 89 transactions
Buy: 581 405 260 \| Sell: 937 995

Wolumen Korelacja

Długi: -0.41 (neutral)

Krótki: -0.89 (strong negative)

Signal:(41.982) Neutral

Summit Therapeutics plc Korelacja

10 Najbardziej pozytywne korelacje
ACST	0.898
TATT	0.892
NPCE	0.892
DRTT	0.89
VSTM	0.884
AVIR	0.881
GLMD	0.881
MREO	0.879
CNXC	0.872
SRPT	0.87

10 Najbardziej negatywne korelacje
MTEK	-0.922
BFRI	-0.905
CINC	-0.873
SNCR	-0.868
MLVF	-0.862
SLDP	-0.858
LEDS	-0.858
PPBT	-0.858
XPDI	-0.856
PMD	-0.852

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Summit Therapeutics plc Korelacja - Waluta/Towar

-0.44
( neutral )

-0.42
( neutral )

0.00
( neutral )

-0.19
( neutral )

0.32
( neutral )

Summit Therapeutics plc Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-2.05M (0.00 %)
EPS:	$-0.990

FY	2023
Przychody:	$0
Zysk brutto:	$-2.05M (0.00 %)
EPS:	$-0.990

FY	2022
Przychody:	$704 295
Zysk brutto:	$-1.81M (-256.95 %)
EPS:	$-0.380

FY	2021
Przychody:	$1 809.00
Zysk brutto:	$1 809.00 (100.00 %)
EPS:	$-0.000960

Financial Reports:

No articles found.

Summit Therapeutics plc

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.